Statements in which the resource exists.
SubjectPredicateObjectContext
pubmed-article:3567010rdf:typepubmed:Citationlld:pubmed
pubmed-article:3567010lifeskim:mentionsumls-concept:C0681876lld:lifeskim
pubmed-article:3567010lifeskim:mentionsumls-concept:C0031327lld:lifeskim
pubmed-article:3567010lifeskim:mentionsumls-concept:C0040879lld:lifeskim
pubmed-article:3567010pubmed:issue6lld:pubmed
pubmed-article:3567010pubmed:dateCreated1987-6-1lld:pubmed
pubmed-article:3567010pubmed:abstractTextThe kinetics of a single 0.5 mg oral dose of the triazolobenzodiazepine hypnotic triazolam, were studied in 54 healthy young men aged 20-44 years, with a mean body weight of 77 kg. Triazolam kinetics were determined from multiple plasma concentrations measured during 14 h post-dose. The overall mean +/- s.e. mean (with range) kinetic variables were: peak plasma concentration, 4.4 +/- 0.3 (1.7-9.4) ng ml-1; time of peak, 1.3 +/- 0.1 (0.5-4.0) h after dose; elimination half-life, 2.6 +/- 0.1 (1.1-4.4) h; total AUC: 19.1 +/- 1.1 (4.4-47.7) ng ml-1 h; oral clearance, 526 +/- 38 (175-1892) ml min-1. All kinetic variables were consistent with Poisson distributions, based on the Kolmogorov-Smirnov Goodness of Fit test. None of the variables fit normal distributions. Four of five were consistent with a log normal distribution. Peak plasma level was highly correlated with clearance (r = -0.85, P less than 0.0001), and AUC (r = 0.85, P less than 0.0001) but not with body weight (r = 0.21, NS). Clearance and body weight were not correlated (r = -0.01). Triazolam clearance may vary widely even within a homogeneous group of healthy young men.lld:pubmed
pubmed-article:3567010pubmed:granthttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:3567010pubmed:granthttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:3567010pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:3567010pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:3567010pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:3567010pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:3567010pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:3567010pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:3567010pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:3567010pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:3567010pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:3567010pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:3567010pubmed:languageenglld:pubmed
pubmed-article:3567010pubmed:journalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:3567010pubmed:citationSubsetIMlld:pubmed
pubmed-article:3567010pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:3567010pubmed:statusMEDLINElld:pubmed
pubmed-article:3567010pubmed:monthDeclld:pubmed
pubmed-article:3567010pubmed:issn0306-5251lld:pubmed
pubmed-article:3567010pubmed:authorpubmed-author:ShaderR IRIlld:pubmed
pubmed-article:3567010pubmed:authorpubmed-author:GreenblattD...lld:pubmed
pubmed-article:3567010pubmed:authorpubmed-author:HarmatzJ SJSlld:pubmed
pubmed-article:3567010pubmed:authorpubmed-author:FriedmanHHlld:pubmed
pubmed-article:3567010pubmed:authorpubmed-author:BursteinE SESlld:pubmed
pubmed-article:3567010pubmed:issnTypePrintlld:pubmed
pubmed-article:3567010pubmed:volume22lld:pubmed
pubmed-article:3567010pubmed:ownerNLMlld:pubmed
pubmed-article:3567010pubmed:authorsCompleteYlld:pubmed
pubmed-article:3567010pubmed:pagination639-42lld:pubmed
pubmed-article:3567010pubmed:dateRevised2009-11-18lld:pubmed
pubmed-article:3567010pubmed:meshHeadingpubmed-meshheading:3567010-...lld:pubmed
pubmed-article:3567010pubmed:meshHeadingpubmed-meshheading:3567010-...lld:pubmed
pubmed-article:3567010pubmed:meshHeadingpubmed-meshheading:3567010-...lld:pubmed
pubmed-article:3567010pubmed:meshHeadingpubmed-meshheading:3567010-...lld:pubmed
pubmed-article:3567010pubmed:meshHeadingpubmed-meshheading:3567010-...lld:pubmed
pubmed-article:3567010pubmed:meshHeadingpubmed-meshheading:3567010-...lld:pubmed
pubmed-article:3567010pubmed:meshHeadingpubmed-meshheading:3567010-...lld:pubmed
pubmed-article:3567010pubmed:meshHeadingpubmed-meshheading:3567010-...lld:pubmed
pubmed-article:3567010pubmed:year1986lld:pubmed
pubmed-article:3567010pubmed:articleTitlePopulation study of triazolam pharmacokinetics.lld:pubmed
pubmed-article:3567010pubmed:publicationTypeJournal Articlelld:pubmed
pubmed-article:3567010pubmed:publicationTypeResearch Support, U.S. Gov't, P.H.S.lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:3567010lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:3567010lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:3567010lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:3567010lld:pubmed